Botulinum toxin treatment for detrusor instability
Record ID 32012000180
English
Authors' recommendations:
Botulinum toxin (BTX), a neurotoxin produced by the bacterium Clostridium (C.) botulinum, is being evaluated as a treatment for urinary incontinence (UI) due to detrusor overactivity (also known as detrusor instability or detrusor hyperreflexia), involuntary contractions of the detrusor muscle, which causes contraction of the bladder. BTX inhibits muscular contraction so it is being investigated as a means to relieve excessive or uncontrolled contractions of the detrusor and improve urinary control.
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=13338
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Botulinum Toxins
- Neuromuscular Agents
- Urinary Bladder, Overactive
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2011 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.